Organogenesis Holdings Inc’s recent filing unveils that its President and CEO Gillheeney Gary S. unloaded Company’s shares for reported $0.19 million on Dec 13 ’24. In the deal valued at $3.36 per share,55,615 shares were sold. As a result of this transaction, Gillheeney Gary S. now holds 3,044,779 shares worth roughly $9.5 million.
Then, Gillheeney Gary S. sold 5,585 shares, generating $19,492 in total proceeds. Upon selling the shares at $3.49, the President and CEO now owns 3,039,194 shares.
Before that, Gillheeney Gary S. sold 157,448 shares. Organogenesis Holdings Inc shares valued at $573,111 were divested by the President and CEO at a price of $3.64 per share. As a result of the transaction, Gillheeney Gary S. now holds 3,143,753 shares, worth roughly $9.81 million.
Lake Street initiated its Organogenesis Holdings Inc [ORGO] rating to a Buy in a research note published on June 28, 2024; the price target was $5. A number of analysts have revised their coverage, including Cantor Fitzgerald’s analysts, who began to cover the stock in early February with a ‘”an Overweight”‘ rating. Morgan Stanley began covering ORGO with “an Equal-weight” recommendation on June 15, 2023. BTIG Research revised its rating on May 24, 2023. It rated ORGO as “a Buy” which previously was an “a Neutral”.
Price Performance Review of ORGO
On Monday, Organogenesis Holdings Inc [NASDAQ:ORGO] saw its stock jump 0.65% to $3.12. Over the last five days, the stock has lost -2.19%. Organogenesis Holdings Inc shares have fallen nearly -2.50% since the year began. Nevertheless, the stocks have fallen -16.35% over the past one year. While a 52-week high of $4.70 was reached on 01/02/25, a 52-week low of $2.16 was recorded on 01/03/25. SMA at 50 days reached $3.45, while 200 days put it at $2.94.
Levels Of Support And Resistance For ORGO Stock
The 24-hour chart illustrates a support level at 3.08, which if violated will result in even more drops to 3.04. On the upside, there is a resistance level at 3.17. A further resistance level may holdings at 3.21. The Relative Strength Index (RSI) on the 14-day chart is 41.44, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.13, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 78.87%. Stochastics %K at 13.90% indicates the stock is a buying.
How much short interest is there in Organogenesis Holdings Inc?
A steep rise in short interest was recorded in Organogenesis Holdings Inc stocks on 2024-12-13, growing by 0.59 million shares to a total of 11.0 million shares. Yahoo Finance data shows the prior-month short interest on 2024-11-15 was 10.41 million shares. There was a rise of 5.37%, which implies that there is a positive sentiment for the stock.
